Brief: Biomerieux Gets U.S. FDA Clearance For Additional Swab To BIOFIRE SPOTFIRE

Biomerieux SA

18/08/2025 17:10

Aug 18 (Reuters) - Biomerieux SA BIOX.PA:

RECEIVES 510(K) CLEARANCE AND CLIA WAIVER FROM U.S. FDA FOR ADDITION OF ANTERIOR NASAL SWAB WITH ITS BIOFIRE® SPOTFIRE® RESPIRATORY/SORE THROAT (R/ST) PANEL MINI TEST

Source text: [ID:]

Further company coverage: BIOX.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))